Laven, Anna http://orcid.org/0000-0003-4405-2462
Deters, Maira Anna
Rose, Olaf
Schwender, Holger
Smaranda, Alexandra
Waltering, Isabell
Laeer, Stephanie
Funding for this research was provided by:
Participants (14950 €)
Pharmabrain GmbH (5500 €)
Article History
Received: 7 July 2017
Accepted: 1 August 2018
First Online: 11 August 2018
Conflicts of interest
: DM, SH, SA and LS declare that they have no conflict of interest. LA is the owner and CEO of Pharmabrain. RO has received lecture fees and reimbursement of conference fees and travel expenses by Bayer AG, Boehringer Ingelheim, Medac, MSD and Omnicell. WI has received lecture fees and reimbursement of conference fees and travel expenses by Medac, MSD and HRS Pharma. Face-to-face training took part in the training pharmacy of Bayer’s Innovation Academy of German Pharmacists.
: This study was partially paid by the course-participants and partially by Pharmabrain, Berlin.